Showing results (841-850 of 6,499) with videos related to

Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|December 22, 2009
Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linkedMarie von Lilienfeld-Toal, Susanne Frank, Christiane Leyendecker, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1985
Defective interleukin-1 production by natural killer cells of patients with cancerJ Herman, M C Kew, A R Rabson
Cancer Immunology, Immunotherapy : CII|March 17, 2009
The effect of aging on OX40 agonist-mediated cancer immunotherapyCarl E Ruby, Andrew D Weinberg
Cancer Immunology, Immunotherapy : CII|March 5, 2009
The importance of the age factor in cancer vaccination at older ageClaudia Gravekamp
Cancer Immunology, Immunotherapy : CII|May 26, 2009
The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantationMark Tuthill, Frederick Chen, Samantha Paston, et al.
Cancer Immunology, Immunotherapy : CII|May 12, 2009
Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicityCristina Garrido, Ignacio Algarra, Isabel Maleno, et al.
Cancer Immunology, Immunotherapy : CII|February 25, 2009
Cancer, aging and immunotherapy: lessons learned from animal modelsJoseph Lustgarten
Cancer Immunology, Immunotherapy : CII|April 28, 2009
Bortezomib pre-treatment prolongs interferon-alpha-induced STAT1 phosphorylation in melanoma cellsGregory B Lesinski, Kristen Benninger, Melanie Kreiner, et al.
Pageof 650